Story M - Search Results

1

Optimizing dose and fractionation for stereotactic body radiation therapy. Normal tissue and tumor control effects with large dose per fraction.

Timmerman R, Bastasch M, Saha D, Abdulrahman R, Hittson W, Story M. Timmerman R, et al. Among authors: story m. Front Radiat Ther Oncol. 2007;40:352-365. doi: 10.1159/000106046. Front Radiat Ther Oncol. 2007. PMID: 17641519 Review.

2

Paclitaxel restores radiation-induced apoptosis in a bcl-2-expressing, radiation-resistant lymphoma cell line.

Nguyen LN, Munshi A, Hobbs ML, Story MD, Meyn RD. Nguyen LN, et al. Among authors: story md. Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):1127-32. doi: 10.1016/s0360-3016(00)01435-8. Int J Radiat Oncol Biol Phys. 2001. PMID: 11240255

3

Cellular responses to ionizing radiation damage.

Li L, Story M, Legerski RJ. Li L, et al. Among authors: story m. Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):1157-62. doi: 10.1016/s0360-3016(00)01524-8. Int J Radiat Oncol Biol Phys. 2001. PMID: 11240259

4

Molecular signatures associated with clinical outcome in patients with high-risk head-and-neck squamous cell carcinoma treated by surgery and radiation.

Giri U, Ashorn CL, Ramdas L, Stivers DN, Coombes K, El-Naggar AK, Ang KK, Story MD. Giri U, et al. Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):670-7. doi: 10.1016/j.ijrobp.2005.08.032. Epub 2005 Nov 10. Int J Radiat Oncol Biol Phys. 2006. PMID: 16289374

5

Stereotactic body radiation therapy: a treatment in need of basic biological research.

Timmerman RD, Story M. Timmerman RD, et al. Among authors: story m. Cancer J. 2006 Jan-Feb;12(1):19-20. doi: 10.1097/00130404-200601000-00004. Cancer J. 2006. PMID: 16613657 No abstract available.

6

Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.

Park C, Papiez L, Zhang S, Story M, Timmerman RD. Park C, et al. Among authors: story m. Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):847-52. doi: 10.1016/j.ijrobp.2007.10.059. Int J Radiat Oncol Biol Phys. 2008. PMID: 18262098

7

Exploring the possibility of unique molecular, biological, and tissue effects with hypofractionated radiotherapy.

Story M, Kodym R, Saha D. Story M, et al. Semin Radiat Oncol. 2008 Oct;18(4):244-8. doi: 10.1016/j.semradonc.2008.04.006. Semin Radiat Oncol. 2008. PMID: 18725111

8

The small-molecule CDK inhibitor, SNS-032, enhances cellular radiosensitivity in quiescent and hypoxic non-small cell lung cancer cells.

Kodym E, Kodym R, Reis AE, Habib AA, Story MD, Saha D. Kodym E, et al. Lung Cancer. 2009 Oct;66(1):37-47. doi: 10.1016/j.lungcan.2008.12.026. Epub 2009 Feb 3. Lung Cancer. 2009. PMID: 19193471

9

SNS-032 prevents hypoxia-mediated glioblastoma cell invasion by inhibiting hypoxia inducible factor-1alpha expression.

Ali MA, Reis A, Ding LH, Story MD, Habib AA, Chattopadhyay A, Saha D. Ali MA, et al. Among authors: story md. Int J Oncol. 2009 Apr;34(4):1051-60. doi: 10.3892/ijo_00000231. Int J Oncol. 2009. PMID: 19287962

10

RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN.

Park S, Zhao D, Hatanpaa KJ, Mickey BE, Saha D, Boothman DA, Story MD, Wong ET, Burma S, Georgescu MM, Rangnekar VM, Chauncey SS, Habib AA. Park S, et al. Among authors: story md. Cancer Res. 2009 May 15;69(10):4107-11. doi: 10.1158/0008-5472.CAN-09-0474. Epub 2009 May 12. Cancer Res. 2009. PMID: 19435890 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

702 results

Search Page